Compound ID | 421

A54145 complex

Class: Lipopeptide

Spectrum of activity: Gram-negative
Institute where first reported: Eli Lilly, US
Year first mentioned: 1988
Highest developmental phase: Preclinical
Development status: Inactive
Reason Dropped: Transient resistance build up through passing Streptococcus sp. 7 times at sublethal concentrations and demonstrates acute mouse toxicity (ICAAC 1988, no.971).

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.